UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000041442
Receipt number R000047306
Scientific Title A study of the effects of food containing dietary fiber on intestinal flora
Date of disclosure of the study information 2020/09/01
Last modified on 2021/08/17 09:27:34

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A study of the effects of food containing dietary fiber on intestinal flora

Acronym

A study of the effects of food containing dietary fiber on intestinal flora

Scientific Title

A study of the effects of food containing dietary fiber on intestinal flora

Scientific Title:Acronym

A study of the effects of food containing dietary fiber on intestinal flora

Region

Japan


Condition

Condition

Healthy adult

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate the effect of legume based foods on diversity of intestinal flora and bowel movements

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Diversity of intestinal flora
(Changes in species-level composition ratios)

Key secondary outcomes

・Intestinal metabolites
・Saliva secretory IgA
・defecation frequency
・Questionnaire about physical condition
and mental status
・the change of body weight


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Self control

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Food

Interventions/Control_1

Control foods(14 times ingestion)-Test foods (28 times ingestion)-Control foods(28 times ingestion)

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

50 years-old >

Gender

Female

Key inclusion criteria

(1) Healthy females aged between 20 and 50.
(2) Defecation frequency 3 to 5 times a week
(3) BMI 23.0 or more and less than 25.0
(4) Those who answered that they felt anxious about their physical condition in the questionnaire survey
(5) Those who answered that they felt stressed in the questionnaire survey
(6) Those who had a cold or flu once within a year

Key exclusion criteria

(1) Those who participated in other clinical trials within 1 month
(2) Those who have taken drugs such as antibiotics that affect the intestinal flora, or those who have taken them within one month
(3) Those who cannot stop the additional intake foods containing live bacteria such as lactic acid bacteria, bifidobacteria, and natto bacteria, foods reinforced with oligosaccharides and dietary fiber, health foods (including special health foods) that are considered to be effective in improving constipation, supplements, and pharmaceutical products during the test period (Excludes those taken before the start of the test)
(4) Those who have a disease that requires urgent treatment or who have serious complications
(5) Those who have a history of gastrointestinal disorders that affect digestive absorption and defecation, or have a history of surgery for them
(6) Those who take medicines that have constipation as a side effect
(7) Those who are judged to be inappropriate as a subject from the answers to the subject background questionnaire
(8) Those who are participating or willing to participate in the clinical test of ingesting other foods or using drugs, the test of applying cosmetics and drugs and so on
(9) Those who have a history of drug dependence or alcohol dependence or current medical history of them
(10) Those who are pregnant, planning to become pregnant, or breastfeeding
(11) Those who have some food allergies

Target sample size

12


Research contact person

Name of lead principal investigator

1st name Takashi
Middle name
Last name Taguchi

Organization

Unlog K.K.

Division name

CEO

Zip code

151-0053

Address

107 New State Menor, 2-23-1, Yoyogi, Shibuya-ku, Tokyo, Japan

TEL

03-6276-5587

Email

tagc@unlog.co.jp


Public contact

Name of contact person

1st name Joto
Middle name
Last name Yoshimoto

Organization

Mizkan Holdings Co., Ltd.

Division name

Central Research Institute

Zip code

475-8585

Address

2-6 Nakamura-Cho, Handa-Shi, Aichi, Japan

TEL

0569-24-5139

Homepage URL


Email

yoshimoto_jyoutou@mizkan.co.jp


Sponsor or person

Institute

Unlog K.K.

Institute

Department

Personal name



Funding Source

Organization

Mizkan Holdings Co., Ltd.

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Unlog K.K.

Address

107 New State Menor, 2-23-1, Yoyogi, Shibuya-ku, Tokyo, Japan

Tel

03-6276-5587

Email

mail@unlog.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 09 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

8

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2020 Year 07 Month 15 Day

Date of IRB

2020 Year 07 Month 17 Day

Anticipated trial start date

2020 Year 09 Month 01 Day

Last follow-up date

2021 Year 02 Month 28 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 08 Month 17 Day

Last modified on

2021 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000047306


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name